HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibitory effect of dietary monoglucosylceramide 1-O-beta-glucosyl-N-2'-hydroxyarachidoyl-4,8-sphingadienine on two different categories of colon preneoplastic lesions induced by 1,2-dimethylhydrazine in F344 rats.

Abstract
Sphingolipids display a wide spectrum of biological activities, including cell growth, differentiation and apoptosis. However, precise mechanisms by which these compounds exert anticancer or cancer-preventive effects are not known. In the present study, we evaluated the preventive efficacy of enriched dietary monoglucosylceramide 1-O-beta-glucosyl-N-2'-hydroxyarachidoyl-4,8-sphingadienine (G(1)CM) on 1,2-dimethylhydrazine (DMH)-induced aberrant crypt foci (ACF) and beta-catenin-accumulated crypt (BCAC) formation in F344 rats during initiation stage. We also examined whether G(1)CM affects cell proliferation and apoptosis in these lesions. Pure G(1)CM was isolated from rice bran. Forty-two rats were divided randomly into five experimental groups. Rats in groups 1-3 were given subcutaneous injections of DMH (40 mg/kg body weight) once a week for 2 weeks. One week before the first injection of DMH, rats in groups 2 and 3 were fed a diet containing 200 and 1,000 p.p.m. G(1)CM, respectively, for 5 weeks. Rats in group 4 were fed a diet containing 1,000 p.p.m. G(1)CM. Rats in group 5 were given the basal diet alone and served as untreated controls. The experiment was terminated 5 weeks after the start. Dietary G(1)CM at both doses (groups 2 and 3) significantly inhibited the induction of ACF and BCAC (P<0.001) when compared to group 1 treated with DMH alone. In groups 2 and 3, the proliferating cell nuclear antigen labeling indices of epithelial cells in ACF and BCAC were also lower than in group 1 (P<0.0001 for ACF, P<0.05 for BCAC). These results, that dietary G(1)CM has possible chemopreventive effects in the present short-term colon carcinogenesis bioassays, suggest that longer exposure may cause suppression of tumor development.
AuthorsMorihiko Inamine, Masumi Suzui, Takamitsu Morioka, Tatsuya Kinjo, Tatsuya Kaneshiro, Tomoko Sugishita, Tadashi Okada, Naoki Yoshimi
JournalCancer science (Cancer Sci) Vol. 96 Issue 12 Pg. 876-81 (Dec 2005) ISSN: 1347-9032 [Print] England
PMID16367907 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright(Cancer Sci 2005; 96: 876-881).
Chemical References
  • 1-O-beta-glucosyl-N-2'-hydroxyarachidoyl-4,8-sphingadienine
  • Anticarcinogenic Agents
  • Carcinogens
  • Glucosylceramides
  • Sphingolipids
  • 1,2-Dimethylhydrazine
Topics
  • 1,2-Dimethylhydrazine
  • Animals
  • Anticarcinogenic Agents (administration & dosage, pharmacology)
  • Carcinogens
  • Colonic Neoplasms (chemically induced, prevention & control)
  • Diet
  • Glucosylceramides (administration & dosage, pharmacology)
  • Male
  • Oryza
  • Precancerous Conditions (chemically induced, prevention & control)
  • Rats
  • Rats, Inbred F344
  • Sphingolipids (administration & dosage, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: